Noah AI Industry News

Delivers real-time biopharma news and signals — powered by AI, curated for professionals.

Health Tech Giants Collaborate to Streamline Medical Record Sharing

Datavant and athenahealth have announced a groundbreaking partnership aimed at revolutionizing the way medical records are requested and shared across healthcare organizations. This collaboration promises to significantly reduce administrative burdens for providers while enhancing data accessibility and security.

NoahAI News10/29/2025

WuXi AppTec Refocuses Strategy with Sale of Clinical Research Units

Chinese pharmaceutical giant WuXi AppTec has announced a significant strategic move, selling off its China-based clinical research operations to sharpen its focus on its core contract research, development, and manufacturing organization (CRDMO) platform. This decision, revealed on October 25, 2025, marks another step in the company's efforts to streamline its operations and prioritize growth in key areas.

NoahAI News10/29/2025

BioMarin to Divest Hemophilia A Gene Therapy Roctavian Amid Ongoing Sales Struggles

BioMarin Pharmaceutical has announced plans to divest its hemophilia A gene therapy, Roctavian, following persistently low sales and commercial challenges. The decision marks a significant shift for the company and highlights the complexities surrounding the commercialization of gene therapies in the pharmaceutical industry.

NoahAI News10/29/2025

Olympus Navigates Challenges and Innovation in Endoscopy Market

Olympus, a global leader in endoscopy, is charting a course through regulatory hurdles while pushing forward with technological advancements in gastrointestinal (GI) robotics and artificial intelligence (AI). The company's recent moves highlight its commitment to maintaining market dominance despite facing quality control issues.

NoahAI News10/29/2025

Novartis Navigates Challenges and Opportunities in Q3 2025

Novartis, the Swiss pharmaceutical giant, reported a mixed bag of results in its third quarter of 2025, showcasing both the challenges faced by its established blockbusters and the promising growth of its newer drugs. Despite headwinds, the company managed to deliver 7% groupwide sales growth, reaching $13.9 billion for the quarter.

NoahAI News10/29/2025

UnitedHealth Charts Recovery Course Amid Challenges in Healthcare Landscape

UnitedHealth Group, a titan in the healthcare industry, is navigating a path to recovery after facing unexpected headwinds in 2025. The company's third-quarter results and revised guidance offer a glimmer of hope for investors, though significant challenges remain on the horizon.

NoahAI News10/29/2025

Novartis Acquires Avidity Biosciences for $12 Billion, Bolstering Neuromuscular Pipeline

Novartis has agreed to acquire Avidity Biosciences for $12 billion, marking a significant expansion of its neuromuscular disease portfolio and betting big on RNA-based therapies. The deal, announced on Sunday, will see Novartis pay $72 per share for the San Diego-based biotech, representing a 46% premium over Avidity's closing price on Friday.

NoahAI News10/29/2025

BridgeBio's Double Victory: Phase 3 Successes Pave Way for FDA Submissions

BridgeBio Pharma, a Bay Area-based biopharmaceutical company, has reported significant advancements in its drug development pipeline, marking a pivotal moment for the company and potential new treatment options for patients with rare diseases.BridgeBio's encaleret, an oral small molecule designed to treat autosomal dominant hypocalcemia type 1 (ADH1), has demonstrated remarkable efficacy in its global phase 3 Calibrate trial. The study showed that 34 out of 45 patients treated with encaleret achieved healthy blood and urine calcium levels, compared to only two patients under standard-of-care treatment.

NoahAI News10/29/2025

Nvidia Partnerships Accelerate AI Innovation in Healthcare and Pharma

Nvidia, the computing giant known for its specialized graphics processors (GPUs), is forging strategic partnerships across the healthcare and pharmaceutical industries to advance artificial intelligence (AI) capabilities. Recent collaborations with Verily, Innovaccer, and Diligent Robotics highlight the growing integration of Nvidia's AI technology stack in precision health, data analytics, and robotics applications.

NoahAI News10/29/2025

Eli Lilly and Nvidia Join Forces to Build Pharma's Most Powerful Supercomputer

In a groundbreaking move set to revolutionize pharmaceutical research and development, Eli Lilly and computing giant Nvidia have announced a collaboration to construct what they claim will be the most powerful supercomputer owned and operated by a pharmaceutical company. This strategic partnership aims to harness the power of artificial intelligence to accelerate drug discovery and development processes.

NoahAI News10/29/2025

CAR T Therapy Shows Promise in Treating Autoimmune Conditions

Bristol Myers Squibb and Cabaletta Bio have reported encouraging results from their Phase I/II clinical trials investigating resecabtagene autoleucel (rese-cel), a CAR T therapy, for the treatment of various autoimmune conditions. The data, presented at the 2025 American College of Rheumatology congress, demonstrate the potential of this innovative approach in addressing immune dysfunction beyond its established use in cancer treatment.

NoahAI News10/28/2025

Medtronic's Renal Denervation Device Shows Promising Long-Term Results in Blood Pressure Reduction

Medtronic, a leading medical technology company, has released three-year data for its renal denervation (RDN) device, Symplicity Spyral, demonstrating significant long-term reductions in blood pressure. The results, presented at the 2025 Transcatheter Cardiovascular Therapeutics conference, offer new insights into the potential of RDN as a treatment for hypertension.

NoahAI News10/28/2025

«1...16 17 18...67 »